Identification and characterization of a novel enhancer in the HTLV-1 proviral genome

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome

Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic virus with constantly active antisense transcription from the proviral genome. Here, Matsuo et al. perform proviral DNA-capture followed by high-throughput sequencing and identify a yet unknown viral enhancer in the middle of the HTLV-1 pro...

Full description

Bibliographic Details
Main Authors:	Misaki Matsuo, Takaharu Ueno, Kazuaki Monde, Kenji Sugata, Benjy Jek Yang Tan, Akhinur Rahman, Paola Miyazato, Kyosuke Uchiyama, Saiful Islam, Hiroo Katsuya, Shinsuke Nakajima, Masahito Tokunaga, Kisato Nosaka, Hiroyuki Hata, Atae Utsunomiya, Jun-ichi Fujisawa, Yorifumi Satou
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-05-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-30029-9

Similar Items

The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach
by: Hiroo Katsuya, et al.
Published: (2019-10-01)

HIV-Tocky system to visualize proviral expression dynamics
by: Omnia Reda, et al.
Published: (2024-03-01)

Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus
by: Paola Miyazato, et al.
Published: (2016-06-01)

HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
by: Paola Miyazato, et al.
Published: (2019-12-01)

HTLV-1 bZIP factor perturbs immune response to the pathogens in vivo by inhibiting IFN-gamma production
by: Matsuoka Masao, et al.
Published: (2011-06-01)

HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
by: Benjy J. Y. Tan, et al.
Published: (2022-10-01)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
by: Choi Ilseung, et al.
Published: (2011-06-01)

M-Sec induced by HTLV-1 mediates an efficient viral transmission.
by: Masateru Hiyoshi, et al.
Published: (2021-11-01)

Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model
by: Kouki Matsuda, et al.
Published: (2023-12-01)

<it>In vivo </it>expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Saito Kousuke, et al.
Published: (2009-02-01)

HTLV-1 bZIP factor-mediated dysfunction of regulatory T cells in vivo
by: Ohshima Kouichi, et al.
Published: (2011-06-01)

Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review
by: Shingo Nakahata, et al.
Published: (2023-10-01)

Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent [version 2; referees: 2 approved]
by: Michi Miura, et al.
Published: (2018-12-01)

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
by: Daisuke Kodama, et al.
Published: (2020-07-01)

HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
by: Nanae Yamamoto-Taguchi, et al.
Published: (2013-09-01)

Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
by: Yorifumi Satou, et al.
Published: (2017-07-01)

Dynamics and consequences of the HTLV-1 proviral plus-strand burst.
by: Saumya Ramanayake, et al.
Published: (2022-11-01)

Quantification of HTLV-I proviral load in experimentally infected rabbits
by: Kindt Thomas J, et al.
Published: (2005-05-01)

HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation
by: Anurag Kulkarni, et al.
Published: (2018-03-01)

In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
by: Mikiko Izaki, et al.
Published: (2021-02-01)

Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
by: Madoka Kuramitsu, et al.
Published: (2023-12-01)

Influence of INF-gamma gene polymorphism in HTLV-1 proviral load
by: Takayanagui Oswaldo M, et al.
Published: (2011-06-01)

HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma
by: Hiroo Katsuya, et al.
Published: (2023-08-01)

Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects
by: Benjamin Usadi, et al.
Published: (2016-08-01)

Multiomics Investigation Revealing the Characteristics of HIV-1-Infected Cells In Vivo
by: Hirofumi Aso, et al.
Published: (2020-07-01)

Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers
by: Ana Paula Silva Champs, et al.
Published: (2019-07-01)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
by: Hiroo Katsuya, et al.
Published: (2018-07-01)

Carga proviral do HTLV-1 e HTLV-2: um método simples através da PCR quantitativa em tempo real HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR
by: Bruna Pedroso Tamegão-Lopes, et al.
Published: (2006-12-01)

The roles of innate and acquired immune responses on HTLV-I infection
by: Shimizu Yukiko, et al.
Published: (2011-06-01)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
by: Yoshihisa Yamano, et al.
Published: (2011-08-01)

Point-of-Care System for HTLV-1 Proviral Load Quantification by Digital Mediator Displacement LAMP
by: Lisa Becherer, et al.
Published: (2021-02-01)

HTLV-1 Proviral Load in Vaginal Fluid Correlates with Levels in Peripheral Blood Mononuclear Cells
by: Alisson de Aquino Firmino, et al.
Published: (2023-05-01)

HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP.
by: Kiran N Meekings, et al.
Published: (2008-03-01)

Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease
by: Olindo Stéphane, et al.
Published: (2005-02-01)

HTLV-1 proviral load levels in adult T-cell leukemia/lymphoma (ATL) in Bahia, Brazil
by: Bittencourt Achilea, et al.
Published: (2011-06-01)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
by: Jeffery, K, et al.
Published: (1999)

HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.
by: Yorifumi Satou, et al.
Published: (2011-02-01)

Damaging the Integrated HIV Proviral DNA with TALENs.
by: Christy L Strong, et al.
Published: (2015-01-01)

Genome-wide RNAi screen identifies MAPK-RPK required for HIV-1 proviral silencing in non-T cell reservoir cell-line model
by: H. Takeuchi, et al.
Published: (2019-12-01)

Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load.
by: Michel E Haziot, et al.
Published: (2019-05-01)